INTAS PHARMACEUTICALS LIMITED

CIN: U24231GJ1985PLC007866 Active Public

Last Updated: Jul 11, 2025

Gujarat

Authorized Capital
₹1,754,667,520
Registered cap. limit
Paid-up Capital
₹0
Actual invested cap.

Registration Details

Registration Date
1985-05-31
ROC
ROC Ahmedabad
Category / Sub-Category
Company limited by shares / Non-government company
Activity
Manufacture of chemical substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;
Last AGM Date
-
Balance Sheet Date
-

Contact Information

Registered Office Address

Corporate House, Near Sola Bridge, S. G. Highway, Thaltej,Ahmedabad,Ahmedabad,Gujarat,380054-India

Directors

19
B
BINISH HASMUKH CHUDGAR
Managing Director
Appointed
01 Oct 2024
Appointed
01 Oct 2024
J
JITESH KISHOREKUMAR GADHIA
Additional Director
Appointed
19 Sep 2024
Appointed
19 Sep 2024
Appointed
31 Jul 2023
S
Appointed
22 May 2020
J
JAYESH SHANTILAL SHAH
Whole-time director
Appointed
21 Mar 2018
Appointed
01 Apr 2015
R
RATNASAMI VENKATESH
Nominee Director
Appointed
13 Nov 2014
Appointed
12 Aug 2011
Appointed
12 Aug 2011
Appointed
09 Feb 2011
Appointed
08 Jun 2007
U
URMISH HASMUKH CHUDGAR
Managing Director
Appointed
30 Sep 1996
N
NIMISH CHUDGAR
Managing Director
Appointed
31 May 1985
Appointed
09 Feb 2011
Resigned
Appointed
09 Feb 2011
Resigned
A
AJIT RASIKLAL SANGHVI
Additional Director
Appointed
09 Feb 2011
Resigned
S
SANJIV DWARKANATH KAUL
Nominee Director
Appointed
05 Jan 2006
Resigned

Charges & Borrowings

No Charges

No registered charges found for this company.

Frequently Asked Questions

What is the CIN of INTAS PHARMACEUTICALS LIMITED?

The CIN is U24231GJ1985PLC007866.

Who are the directors?

Directors include: BINISH HASMUKH CHUDGAR, HASMUKH CHUDGAR, JITESH KISHOREKUMAR GADHIA, RAKESH BAMZAI, ARCHANA RAVINDRARAI DHOLAKIA, SANJAY KUKREJA, JAYESH SHANTILAL SHAH, KUSUMBEN HASMUKHBHAI CHUDGAR, RATNASAMI VENKATE.